These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 9146775
61. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity. Netzer P, Brabetz-Höfliger A, Bründler R, Flogerzi B, Hüsler J, Halter F. Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722 [Abstract] [Full Text] [Related]
62. The acidity index: a simple approach to the measurement of gastric acidity. Tutuian R, Castell DO, Xue S, Katz PO. Aliment Pharmacol Ther; 2004 Feb 15; 19(4):443-8. PubMed ID: 14871284 [Abstract] [Full Text] [Related]
63. Studies of various administration methods for lansoprazole injection using 24-hour intragastric pH monitoring. Inoue M, Nakamura M. J Clin Gastroenterol; 1995 Feb 15; 20 Suppl 2():S17-21. PubMed ID: 7594332 [Abstract] [Full Text] [Related]
64. Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress. Otani Y, Kitajima M, Sugiyama M, Watanabe Y, Aoki T. J Clin Gastroenterol; 1995 Feb 15; 20 Suppl 2():S22-6. PubMed ID: 7594333 [Abstract] [Full Text] [Related]
65. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats. Šutalo S, Ruetten M, Hartnack S, Reusch CE, Kook PH. J Vet Intern Med; 2015 Feb 15; 29(3):840-6. PubMed ID: 25966746 [Abstract] [Full Text] [Related]
66. A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions. Yoshida N, Yoshikawa T, Tanaka Y, Fujita N, Kassai K, Naito Y, Kondo M. Aliment Pharmacol Ther; 2000 Apr 15; 14 Suppl 1():74-81. PubMed ID: 10807407 [Abstract] [Full Text] [Related]
67. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group. Agrawal NM, Campbell DR, Safdi MA, Lukasik NL, Huang B, Haber MM. Arch Intern Med; 2000 May 22; 160(10):1455-61. PubMed ID: 10826458 [Abstract] [Full Text] [Related]
68. Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects. Suzuki T, Yamaguchi T, Odaka T, Kobayashi M, Seza A, Kouzu T, Yokosuka O. Aliment Pharmacol Ther; 2008 Jan 01; 27(1):66-71. PubMed ID: 17922801 [Abstract] [Full Text] [Related]
69. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration. Lachman L, Howden CW. Am J Gastroenterol; 2000 Jan 01; 95(1):57-61. PubMed ID: 10638559 [Abstract] [Full Text] [Related]
70. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Netzer P, Gaia C, Sandoz M, Huluk T, Gut A, Halter F, Hüsler J, Inauen W. Am J Gastroenterol; 1999 Feb 01; 94(2):351-7. PubMed ID: 10022628 [Abstract] [Full Text] [Related]
71. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs. Uchiyama K, Wakatsuki D, Kakinoki B, Takeuchi Y, Araki T, Morinaka Y. J Pharm Pharmacol; 1999 Apr 01; 51(4):457-64. PubMed ID: 10385219 [Abstract] [Full Text] [Related]
72. Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole. Robinson M, Rodriguez-Stanley S, Ciociola AA, Filinto J, Zubaidi S, Miner PB, Gardner JD. Dig Dis Sci; 2002 Feb 01; 47(2):265-73. PubMed ID: 11855540 [Abstract] [Full Text] [Related]
73. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial. Russo A, Dattilo M. Ital J Gastroenterol Hepatol; 1997 Aug 01; 29(4):312-9. PubMed ID: 9476183 [Abstract] [Full Text] [Related]
74. Clinical study on the pathophysiology and treatment of PPI-resistant ulcers. Ashida K, Sakaguchi M, Tanaka M, Takiuchi H, Egashira Y, Katsu K. J Clin Gastroenterol; 1995 Aug 01; 20 Suppl 2():S67-71. PubMed ID: 7594345 [Abstract] [Full Text] [Related]
75. The effect of intravenous pantoprazole and ranitidine for improving preoperative gastric fluid properties in adults undergoing elective surgery. Memiş D, Turan A, Karamanlioglu B, Saral P, Türe M, Pamukçu Z. Anesth Analg; 2003 Nov 01; 97(5):1360-1363. PubMed ID: 14570652 [Abstract] [Full Text] [Related]
76. Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study. Hirschowitz BI, Simmons J, Mohnen J. Aliment Pharmacol Ther; 2001 Nov 01; 15(11):1795-806. PubMed ID: 11683694 [Abstract] [Full Text] [Related]
77. Maximal acid reflux control for Barrett's oesophagus: feasible and effective. Srinivasan R, Katz PO, Ramakrishnan A, Katzka DA, Vela MF, Castell DO. Aliment Pharmacol Ther; 2001 Apr 01; 15(4):519-24. PubMed ID: 11284781 [Abstract] [Full Text] [Related]
78. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man. Grimley CE, West JM, Loft DE, Cottrell J, Mann SG, Stauffer L, Nwokolo CU. Aliment Pharmacol Ther; 1996 Oct 01; 10(5):743-7. PubMed ID: 8899082 [Abstract] [Full Text] [Related]
79. Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial. Michel P, Lemaire M, Colin R, Bommelaer G, Rambaud JC, Dupas JL, Bigard MA, Verwaerd JC. Aliment Pharmacol Ther; 1994 Feb 01; 8(1):119-22. PubMed ID: 8186337 [Abstract] [Full Text] [Related]
80. Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism. Chey WD, Woods M, Scheiman JM, Nostrant TT, DelValle J. Am J Gastroenterol; 1997 Mar 01; 92(3):446-50. PubMed ID: 9068466 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]